Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Beta Drugs Ltd.
NSE: BETA
|
BSE: 531481
|
ISIN: INE351Y01019
|
Industry: Pharmaceuticals
|
1809.9500
54.15
(
3.08
%)
NSE
Mar 18, 2025
15:31 PM
64.54% Gain from 52W Low
Volume:
1,300
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Beta Drugs Ltd.
16 May 2024
1809.95
3.08%
Beta Drugs Ltd | H2FY24 Result Update
Buy:
Beta Drugs Ltd.
by
Edelweiss
Target: 1600 | Target met
Target
Edelweiss
Deepening its roots in the market
Beta Drugs Ltd. is trading
below its 50 day SMA
of 1813.2
More from Beta Drugs Ltd.
Recommended
Five stocks to buy from analysts this week - March 18, 2025
The Baseline |
18 Mar 2025, 05:17PM
Market closes higher, HUL gets approval to acquire Minimalist's parent firm for Rs 2,670 crore
Trendlyne Marketwatch |
18 Mar 2025, 04:04PM
Musk, Adani, and the double-edged sword of politics | Screener: Stocks with high buy calls from analysts
The Baseline |
15 Mar 2025